Morgan Stanley raised the firm’s price target on CME Group to $225 from $222 and keeps an Equal Weight rating on the shares. In a preview for the Brokers and Exchanges group, the firm notes that its Q1 EPS estimates are revised 1% lower across brokers, 4% higher across market infrastructure names and 1% higher across exchanges on average. Across the group, the firm’s price targets are 13% higher on average for 9% upside, driven by a 12% lift in target 2024 multiples and 2% higher 2025 EPS estimates on average.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group downgraded to Hold from Buy at Deutsche Bank (earlier)
- CME Group reached ADV of 24.3M contracts in March
- CME stock is hot, could catch a chill on lower interest rates, Barron’s says
- CME Group Enhances Stock Plan with New Vesting Provisions
- CME Group price target raised to $245 from $225 at Argus